WO1998051238A1 - Expandable stent and method for production of same - Google Patents
Expandable stent and method for production of same Download PDFInfo
- Publication number
- WO1998051238A1 WO1998051238A1 PCT/CA1998/000471 CA9800471W WO9851238A1 WO 1998051238 A1 WO1998051238 A1 WO 1998051238A1 CA 9800471 W CA9800471 W CA 9800471W WO 9851238 A1 WO9851238 A1 WO 9851238A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stent
- tubular wall
- struts
- interconnection point
- expandable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91525—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91575—Adjacent bands being connected to each other connected peak to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/901—Method of manufacturing prosthetic device
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/496—Multiperforated metal article making
Definitions
- the present invention relates to an expandable stent and to a method for production of same.
- Stents are generally known. Indeed, the term “stent” has been used interchangeably with terms such as “intraluminal vascular graft” and “expansible prosthesis”. As used throughout this specification the term “stent” is intended to have a broad meaning and encompasses any expandable prosthetic device for implantation in a body passageway (e.g. a lumen or artery).
- a body passageway e.g. a lumen or artery
- body passageway is intended to have a broad meaning and encompasses any duct (e.g. natural or iatrogenic) within the human body and can include a member selected from the group comprising: blood vessels, respiratory ducts, gastrointestinal ducts and the like.
- Stent development has evolved to the point where the vast majority of currently available stents rely on controlled plastic deformation of the entire structure of the stent at the target body passageway so that only sufficient force to maintain the patency of the body passageway is applied during expansion of the stent.
- a stent in association with a balloon, is delivered to the target area of the body passageway by a catheter system.
- the balloon is expanded thereby plastically deforming the entire structure of the stent so that the latter is urged in place against the body passageway.
- the amount of force applied is at least that necessary to expand the stent (i.e., the applied the force exceeds the minimum force above which the stent material will undergo plastic deformation) while maintaining the patency of the body passageway.
- the balloon is deflated and withdrawn within the catheter, and is subsequently removed.
- the stent will remain in place and maintain the target area of the body passageway substantially free of blockage (or narrowing). See, for example, any of the following patents:
- Lau teaches a self-expandable, foldable stent which may be delivered using a catheter or other technique.
- the purported point of novelty in Lau relates to a stent which may be folded along its longitudinal axis. The folding is accomplished by conferring bending and twisting stresses to the stent, which stresses, for the material used to produce the stent, do not exceed that minimum stresses above which plastic deformation of the stent will occur - i.e., application of these stresses to the stent results in the storage of mechanical energy in the stent but does not result in the occurrence of any plastic deformation.
- the stent disclosed by Lau is disadvantageous since a relatively complicated folding protocol is needed.
- Lau teaches that the stent is folded into "a loose-C configuration" ( Figures 33A and 33B), "a rolled configuration” ( Figures 33C and 33D) or "a triple lobed configuration” ( Figures 33E and 33F).
- the stent taught by Lau is also disadvantageous since, after it is folded (and thus contains the bending/twisting stresses described above), the stent must be restrained mechanically from spontaneous expansion - see, for example, Figures 35A, 35B, 36A, 36B, 39 and 40 of Lau which illustrate complicated tethering systems for mechanically restraining the folded stent from spontaneous expansion.
- a stent having a multiplicity of closed circular structures connected by a series of longitudinals.
- the stent is initially produced in a pre- deployment form comprising ovals connected by the longitudinals (see Figures 4 and 5).
- the pre-deployment form of the stent is than placed on the end of a balloon stent delivery catheter and the ovals are folded about their minor axis by securing the ovals at each end of the structure and translating a pair of opposed longitudinals (see Figure 6).
- a disadvantage of this approach is that, during the folding step, plastic deformation of the stent structure unavoidable since folding is accomplished by securing selected portions of the stent while translating other portions of the stent.
- the disadvantages are heightened if the stent undergoes plastic deformation during adaption of the unexpanded stent to a delivery system prior to expansion.
- a further disadvantage of this approach is the need have distinct unfolded pre-deployment (i.e., post-production/no balloon), folded pre- deployment (i.e., on balloon) and post-deployment forms of the stent. Accordingly, it would be desirable to have an improved stent which overcomes these disadvantages. It would be further desirable if the improved stent could be manufactured readily.
- the present invention provides an expandable stent comprising a proximal end and a distal end in communication with one another, a tubular wall disposed between the proximal end and the distal end, the tubular wall having a longitudinal axis and a porous surface defined by a plurality of interconnecting struts, a series of the struts connected to one another at an interconnection point, the struts being reversibly hingable at the interconnection point between a first, contracted position and a second, expanded position, the stent being unrestrained in and expandable from the first position to the second position upon the application of a radially outward force on the stent.
- the present invention provides an expandable stent comprising a proximal end and a distal end in communication with one another, a tubular wall disposed between the proximal end and the distal end, the tubular wall having a longitudinal axis and a porous surface defined by a plurality of interconnecting struts, a series of the struts connected to one another at a plastically bendable interconnection point, the struts being reversibly hingable at the plastically bendable interconnection point between a first, contracted position and a second position, expanded position, the stent being expandable from the first position to the second position upon the application of a radially outward force on the stent.
- the present invention provides a process for producing a stent comprising a proximal end and a distal end in communication with one another, a tubular wall disposed between the proximal end and the distal end, the tubular wall having a longitudinal axis and a porous surface defined by a plurality of interconnecting struts, a series of the struts connected to one another at an interconnection point, the struts being reversibly hingable at the interconnection point between a first, unrestrained contracted position and a second, expanded position, the process comprising the step of applying a radially compressing the stent in the second position to produce the stent in first position.
- the present invention provides a process for producing a stent comprising a proximal end and a distal end in communication with one another, a tubular wall disposed between the proximal end and the distal end, the tubular wall having a longitudinal axis and a porous surface defined by a plurality of interconnecting struts, a series of the struts connected to one another at an interconnection point, the struts being reversibly hingable at the interconnection point between a first, unrestrained, contracted position and a second position, expanded position, the process comprising the steps of: (i) selectively removing portions of a solid tubular wall having a diameter substantially the same as that of the stent in the second position to produce a multiple-stent tube defined by multiple sections of the porous surface connected to one another by a series of radially disposed connecting members;
- the present inventor has developed a novel stent which is fundamentally different from stents produced heretofore.
- the present stent is expandable from a first, contracted position to a second, expanded position without the stent undergoing significant plastic deformation throughout its structure. Further, in the first, contracted position the present stent, unlike the stent of Lau described above, has no mechanical forces stored therein. Accordingly, a distinct advantage of the present stent over the stent of Lau is that, in the contracted state, the present stent does not have to be mechanically restrained - i.e., in the present stent may be consider to be mechanically unrestrained in the contracted state.
- a preferred feature of the present stent is that, in the contracted state, it generally assumes the structure of a tubular wall having a substantially circular cross-section.
- a further preferred feature of the present stent is that it has substantially the same cross-sectional shape in the first, contracted (i.e, unexpanded) state and the second, expanded shape. When compared to the stent of Lau and Fishcell, this feature of the present stent is advantageous since it facilitates even expansion of the stent during deployment.
- intersection point In the present stent, a series of the struts defining the porous surface of the stent are connected at an intersection point.
- This intersection point actually functions as a hinge about which the stent may be transformed from the contracted state to the expanded state or vice versa.
- the intersection point (only) undergoes a minor plastic bending during hinging of the stent between the contracted and expanded states.
- the specific shape of the compression means disposed in the longitudinal strut is not particularly restricted provided that it serves to minimize or inhibit lengthening of the stent when it is transformed from the unexpanded state to the expanded state, or vice versa.
- the compression means comprises at least one lateral section disposed in the longitudinal strut, more preferably at least a first lateral section and a second lateral section disposed in the longitudinal strut.
- lateral section is meant a section of the longitudinal strut which is bowed in or out of (i.e., radially from) the strut.
- the apex of the lateral section may be pointed, rounded or substantially flat.
- the two sections may be symmetric or asymmetric (in the case of asymmetric this includes two sections of the same shape but different size and two sections of different and size). Further, when the compression means comprises a first lateral section and a section lateral section, the sections may be bowed in the same or opposite direction.
- a particularly preferred embodiment of the compression means comprises a sinusoidal or S-shaped section (an example of such a section is illustrated herein and discussed below).
- the present process essentially comprises starting with a tubular wall having a porous surface defined by a plurality of interconnecting struts and thereafter hinging or compressing the tubular wall, in essence, to produce the stent in an unrestrained, contracted state.
- An advantage of this approach is that the desired porous surface after deployment of the stent is conferred to the tubular wall during production of the stent.
- a further advantage of this approach is that the present stent may be hinged between the first, contracted (i.e., unexpanded) position and the second, expanding position without the need to produce an intermediate position.
- the present approach is initially to produce the stent in the desired final form (i.e., the second, expanded position) and thereafter radially compress the stent to a predeployment form (i.e., the first, contracted position).
- the advantage of the present approach is that expansion of the stent to the second, expanded position is greatly facilitated.
- the stent is produced initially in the desired configuration, then radially compressed (or otherwise folded) to a contracted position and finally returned to the original desired configuration via expansion by a balloon or other mechanical means thereby simplifying production and use;
- the structure of the stent has not undergone any plastic deformation which obviates or mitigates the occurrence of micro-cracks and/or thinning;
- Figure 1 illustrates a perspective view of a solid tubular wall useful in a preferred initial step in the present process
- Figure 2 illustrates a schematic of a programmable, computer controlled laser cutting system useful in a preferred step of the present process
- Figure 3 illustrates a perspective view of the tubular wall in Figure 1 after selective removal of portions thereof;
- Figure 4 illustrates a section along line IV-IV in Figure 3;
- Figures 5 and 6 illustrate explode views of a portion of the tubular wall illustrated in Figure 3;
- Figure 7 illustrates a side elevation of a preferred step of the present process
- Figure 8 illustrates a section along line NIII-VIII in Figure 7
- Figures 9 and 10 illustrate exploded views of a portion of the tubular wall before and after processing as illustrated in Figure 7;
- Figures 11-13 illustrate a first alternative to the step of the present process illustrated in Figure 7;
- Figures 14 and 15 illustrate a second alternative to the step of the present process illustrated in Figure 7;
- Figure 16 illustrates a schematic of a electropolishing step preferably used in the present process
- Figure 17 illustrates a schematic of a gold deposition step preferably used in the present process
- Figure 18 illustrates a preferred, final step in the present process.
- the specific design of the porous surface is not particularly restricted.
- At least two of the struts meet at the intersection point to define an acute angle.
- this acute angle becomes further reduced.
- the preferred repeating pattern is a polygon having a pair of side walls substantially parallel to the longitudinal axis of the stent passageway in question, a first concave-shaped wall and a second convex-shaped wall connecting the side walls.
- Various preferred repeating patterns which are useful in the context of the present stent are disclosed in the following copending patent applications:
- the present stent may be constructed from any suitable starting material.
- the starting material is a thin tube of a metal or alloy.
- the starting material may be one which is plastically deformable - non-limiting examples of such a material include stainless steel, titanium, tantalum and the like.
- the starting material may be one which expands via temperature-dependent memory (i.e., a material which will expand upon reaching a certain temperature) - non-limiting examples of such a material include nitinol and the like. In this embodiment, the use of such a temperature-dependent memory is greatly facilitated when compared to the prior art use of these materials.
- the stent is produced in the expanded state, heat annealed in this state, chilled and radially compressed (as will be described below) to a contracted stated, all without subjecting the structure to expansion and stretching. In some cases, it may be desirable to restrain the stent in the contracted state.
- the stent of the present invention may further comprise a coating material thereon.
- the coating material may be disposed continuously or discontinuously on the surface of the stent. Further, the coating may be disposed on the interior and/or the exterior surface(s) of the stent.
- the coating material may be one or more of a biologically inert material (e.g. to reduce the thrombogenicity of the stent), a medicinal composition which leaches into the wall of the body passageway after implantation (e.g. to provide anticoagulant action, to deliver a pharmaceutical to the body passageway and the like) and the like.
- the stent is preferably provided with a biocompatible coating, in order to minimize adverse interaction with the walls of the body vessel and/or with the liquid, usually blood, flowing through the vessel.
- the coating is preferably a polymeric material, which is generally provided by applying to the stent a solution or dispersion of preformed polymer in a solvent and removing the solvent.
- Non-polymeric coating material may alternatively be used.
- Suitable coating materials, for instance polymers may be polytetraflouroethylene or silicone rubbers, or polyurethanes which are known to be biocompatible.
- the polymer has zwitterionic pendant groups, generally ammonium phosphate ester groups, for instance phosphoryl choline groups or analogues thereof.
- Suitable polymers are described in published International patent applications WO-A-93/16479 and WO-A-93/15775. Polymers described in those specifications are hemo-compatible as well as generally biocompatible and, in addition, are lubricious. When a biocompatible coating is used, It is important to ensure that the surfaces of the stent are completely coated in order to minimize unfavourable interactions, for instance with blood, which might lead to thrombosis.
- This good coating can be achieved by suitable selection of coating conditions, such as coating solution viscosity, coating technique and/or solvent removal step.
- the coating if present, can be applied to the stent in the expanded or contracted state.
- the stent is applied to the coating in the contracted state.
- solid tube 10 of a starting material for the present process.
- the nature of solid tube 10 is not particularly restricted and includes all materials conventionally used to produce stents.
- solid tube 10 is constructed of a plastically deformable material. As discussed above, a non-limiting example of such a material is stainless steel.
- solid tube 10 is constructed of a material which will expand when a certain temperature is reached.
- the material may be a metal alloy (e.g. nitinol) capable of self-expansion at a temperature of at least about 30°C, preferably in the range of from about 30° to about 40°C.
- solid tube 10 has a thickness in the range of from about 0.003 to about 0.015 inches.
- Solid tube 10 is then subjected to processing which results in removal of a portion thereof to define a porous surface. While the precise nature of this processing is not particularly restricted, it is preferred that the processing by effected on a computer programmable, laser cutting system.
- System 100 comprises a power supply 110, a computer console 120 and a work station 150.
- Power supply 110 is conventional.
- Computer console 120 is also conventional and comprises a monitor 112, a computer 114, a keyboard, 116, a system start switch 118 and system stop switch 120.
- Work station 150 comprises a laser 152 mounted on a pair of supports 154,156.
- Laser 152 comprises a laser emission head 153.
- Support 154 is in turn supported on a support 158.
- the combination of supports 154,158 is adapted to have an opening therebetween for receiving a tubular material.
- supports 154,158 may be adapted to be moveable toward support 156 thereby supporting the tubular material as it is fed under head 153.
- supports 154,158 may be fixed within work station 150 and a supplementary, moveable support (not shown) may be provided for supporting the tubular material as it is fed under head 153.
- Support 156 is adapted to receive and translate a tubular starting material therethrough in the general direction of head 153.
- a basin 160 is disposed below head 153.
- a suitable such system is known in the art as the LPLS-100 Series Stent Cutting Machine.
- system 100 may be operated in the following manner.
- Solid tube 10 is placed in work station 150 by guiding an end thereof into support 156 and supporting the opposite end thereof between supports 154,158.
- Solid tube 10 is then fed through support 156 to a region A wherein a laser beam is emitted from head 153 and serves to cut solid tube 10 to produce a porous surface thereof having a preselected design.
- a preferred product of laser cutting system 100 is illustrated in Figure 3 as a multiple stent tube 20 - this can be made of a plastically deformable material such as stainless steel or a temperature-dependent memory material such as nitinol.
- multiple stent tube 20 comprises three distinct stent sections A,B,C.
- Multiple stent tube 20 may comprise many more stent sections (not shown) and, in practice, may be up to 1 metre or more in length. It will be appreciated by those of skill in the art that, for illustrative purposes, the porous surface of each stent section A,B,C is somewhat abbreviated (i.e., number rings of polygons). Stent section A is connected to stent section B by a plurality of connecting tabs 22. Similarly, stent section B is connected to stent section C by a plurality of connecting tabs 24. At one end of multiple stent tube 20 is a plurality of generally elongate pull tabs 28. Stent section A is connected to pull tabs 28 by a plurality of connecting tabs 26. As illustrated, each ring of connecting tabs 22,24,26 and the ring of pull tabs 28 are in spaced relationship to one another.
- each of stent sections A,B,C comprises a tubular wall having a porous surface.
- the porous surface is made up of a plurality of longitudinal struts 30, first radial struts 32 and second radial struts 34.
- Some of longitudinal struts 30 comprise a compressible portion 36.
- Longitudinal connecting members 33 are disposed between adjacent compressible portions 36.
- multiple stent tube 20 As illustrated, multiple stent tube 20, as it emanates from laser cutting system 100, comprises a number of remelt portions 38.
- the formation of such remelt portions is a conventional byproduct of precision laser cutting techniques.
- remelt portions may be removed by labour-intensive techniques such as buffing, polishing or chemical postprocessing.
- labour-intensive polishing techniques may be obviated by the present process.
- the inlet of sink die 40 has a diameter equivalent to the outer diameter of the stent in a deployed state whereas the outlet of sink die 40 has a diameter equivalent to the desired diameter of the stent in an unexpanded state.
- connecting tabs 22,24,26 and pull tabs 28 are of a width such that, during pulling of multiple stent tube 20 through sink die 40, they are generally unaffected.
- each interconnected pair of first radial strut 32 and second radial strut 34 form an acute angle (i.e., the angle between interconnected first radial strut 32 and second radial strut 34 is less than about 90°) opening away from sink die 40. It is believed that the present process will also be useful in the case where interconnected pairs of first radial strut 32 and second radial strut 34 form an obtuse angle (i.e., the angle between interconnected first radial strut 32 and second radial strut 34 is greater than about 90° but less than 180°).
- each pull tab 28 is selected such that the aggregate thereof for all of pull tabs 28 is equivalent to the circumference of the stent in the unexpanded state.
- connection point 35 is functioning as a solid state hinge which allows for radial compression of multiple stent tube 20 without lengthening thereof while avoiding any appreciable plastic deformation of struts 30,32,33,34.
- a plurality of longitudinal rollers 50 is arranged to provide a generally U-shaped trough having a tapered cross-section. Further, each longitudinal roller 50 itself has a tapered cross-section.
- multiple stent tube 20 (in this embodiment, the creation of pull tabs 28 would not be required) is fed to the plurality of longitudinal rollers 50 in the direction of arrow G.
- Longitudinal rollers 50 are rotated in the directions illustrated in Figures 12 and 13 by any suitable means (not shown). This results in radial compression of multiple stent tube 20 as discussed hereinabove with reference to Figures 9 and 10.
- four longitudinal rollers 50 have been illustrated, those of skill in the art will readily appreciate that the specific number of rollers used in this embodiment is not particularly restricted.
- FIG. 14 and 15 there is illustrated yet a further alternative to the sink die/hydraulic puller illustrated in Figure 7.
- a series of paired rollers defining an opening of decreasing diameter is used to radially compress multiple stent tube 20 in the manner described hereinabove with reference to Figures 9 and 10.
- an initial pair of rollers 52,54 is provided for receiving multiple stent tube 20.
- an intermediate pair of rollers 56,58 which, in turn, are followed by a final pair of rollers 60,62.
- the cross-section of the pairs of rollers presented to multiple stent tube 20 is illustrated.
- each pair of rollers combines to define an opening 64 through which multiple stent tube 20 passes.
- opening 64 defined by rollers 52,54 approximate the diameter of multiple stent tube 20.
- Successive pairs of rollers 56,58 and 60,62 are adapted such that opening 64 is progressively decreased.
- the formation of pull tabs 28 as illustrated in Figure 7 is not required.
- three pairs of rollers have been illustrated, those of skill in the art will readily appreciate that the specific number of rollers used in this embodiment is not particularly restricted.
- a preferred step in the present process is illustrated.
- multiple stent tube 20 is subjected to an electropolishing step.
- electropolishing is done in a container 70 having dispensed therein a liquid 72 which functions both as an electrolyte and a chemical etchant for removal of a thin layer of material from multiple stent tube 20.
- a liquid 72 which functions both as an electrolyte and a chemical etchant for removal of a thin layer of material from multiple stent tube 20.
- individual stents are placed in container 70 for treatment in this fashion.
- container 70 functions as one electrode and the stent is directly connected to the other electrode.
- Electrolysis is then conducted facilitating chemical etching resulting in electropolishing of the stent.
- a distinct disadvantage in the prior art approach is the requirement that a portion of the stent be directly connected to one electrode since the result of this is that electropolishing will not take place at the connection point.
- a distinct advantage of the present process is that multiple stent tube 20 can be directly connected to one of the electrodes via one or more of the connection tabs (i.e., one or more of connecting tabs 22,24,26) or pull tabs (if present, i.e., pull tabs 28) of multiple stent tube 20. Since these connecting tabs/pull tabs (if present) do not form part of the finished stent (discussed hereinbelow), it is of no consequence that electropolishing does not take place on the portion of multiple stent tube 20 which is directly connected to the electrode.
- Electropolished multiple stent tube 20, now illustrated in Figure 17, may then be passed to a radio-opaque marker application station (not shown).
- a radio-opaque marker application station (not shown).
- the marker is disposed on each individual stent as one of the last steps in the manufacturing process. This renders marker application as the majority of expense in the overall manufacture of stainless steel stents.
- multiple stent tube 20 contains a number of stents and can be of a length up to 1 metre or more. This renders multiple stent tube 20 much easier to handle than individual stents and significantly reduces the costs of applying a radio-opaque marker - this is a significant advantage of the present process.
- a final preferred step in the present process is illustrated schematically in
- FIG 18 As illustrated, multiple stent 20 is subjected to a laser (or other) cutting technique effectively to remove connecting tabs 22,24,26 and pull tabs 28.
- the product of the final step illustrated in Figure 18 is a plurality of stent sections A,B,C, together with scrap by products comprising connecting tabs 22,24,26 and pull tabs 28.
- the illustrated embodiment of the present process may be regarded as a batch process wherein a batch of stents is made from a single length of tubular starting material.
- the length of the tube is not particularly restricted in the context of the invention and is more dependent on the practical size equipment used to treat the tubular starting material (e.g. the laser cutting system).
- the stent produced according to the present process may be used in a conventional manner.
- the significant advantage of the present stent is that it may be expanded by unhinging of first radial struts 32 and the second radial struts 34 about connection point 35. This is effected by a plastic bending at connection point 35.
- the important advantages of the present stent are: (i) it may be produced such that it does not need to be restrained in the unexpanded state; (ii) expansion of the stent in a lumen may be effected without the occurrence of plastic deformation of struts 32,34,36; and (iii) expansion of the stent in a lumen may be effected without any appreciable change in the length of the stent - to the knowledge of the Applicant, a stent having this combination of features heretofore has been unknown.
- a stent having these advantages mitigates or obviates the occurrence of thinning and/or micro-cracks in the expanded stent to which prior stents have been susceptible.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/423,813 US6344055B1 (en) | 1997-05-14 | 1998-05-14 | Method for production of an expandable stent |
CA002308396A CA2308396A1 (en) | 1997-05-14 | 1998-05-14 | Expandable stent and method for production of same |
AU74209/98A AU7420998A (en) | 1997-05-14 | 1998-05-14 | Expandable stent and method for production of same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4649797P | 1997-05-14 | 1997-05-14 | |
US60/046,497 | 1997-05-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998051238A1 true WO1998051238A1 (en) | 1998-11-19 |
Family
ID=21943781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA1998/000471 WO1998051238A1 (en) | 1997-05-14 | 1998-05-14 | Expandable stent and method for production of same |
Country Status (4)
Country | Link |
---|---|
US (1) | US6344055B1 (en) |
AU (1) | AU7420998A (en) |
CA (1) | CA2308396A1 (en) |
WO (1) | WO1998051238A1 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000035378A1 (en) * | 1998-12-18 | 2000-06-22 | Cook Incorporated | Cannula stent |
WO2001061080A1 (en) * | 2000-02-14 | 2001-08-23 | Advanced Cardiovascular Systems, Inc. | Electro-polishing fixture and electrolyte solution for polishing nitinol stents and method of using same |
EP1132058A1 (en) * | 2000-03-06 | 2001-09-12 | Advanced Laser Applications Holding S.A. | Intravascular prothesis |
EP1266637A1 (en) * | 2001-06-11 | 2002-12-18 | Cordis Neurovascular, Inc. | Method of manufacturing small profile medical devices |
EP1294309A1 (en) * | 2000-05-22 | 2003-03-26 | Jungsung Medical Co. LTD | Metal stent for insertion in coronary artery |
EP1413261A1 (en) * | 2002-10-23 | 2004-04-28 | Medtronic Vascular, Inc. | Stent with detachable ends |
US6743252B1 (en) | 1998-12-18 | 2004-06-01 | Cook Incorporated | Cannula stent |
EP1557140A2 (en) * | 2001-02-05 | 2005-07-27 | Conor Medsystems, Inc. | Expandable medical device |
US7389670B1 (en) | 2004-07-26 | 2008-06-24 | Abbott Laboratories | Stent crimping system |
US7722661B2 (en) | 2007-12-19 | 2010-05-25 | Boston Scientific Scimed, Inc. | Stent |
Families Citing this family (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2079417C (en) * | 1991-10-28 | 2003-01-07 | Lilip Lau | Expandable stents and method of making same |
US6709465B2 (en) | 1999-03-18 | 2004-03-23 | Fossa Medical, Inc. | Radially expanding ureteral device |
US6273911B1 (en) | 1999-04-22 | 2001-08-14 | Advanced Cardiovascular Systems, Inc. | Variable strength stent |
US6702848B1 (en) * | 1999-07-20 | 2004-03-09 | Peter Paul Zilla | Foam-type vascular prosthesis with well-defined anclio-permissive open porosity |
US6767544B2 (en) * | 2002-04-01 | 2004-07-27 | Allergan, Inc. | Methods for treating cardiovascular diseases with botulinum toxin |
US20060216313A1 (en) * | 1999-08-10 | 2006-09-28 | Allergan, Inc. | Methods for treating a stricture with a botulinum toxin |
US6679911B2 (en) * | 2001-03-01 | 2004-01-20 | Cordis Corporation | Flexible stent |
US6790227B2 (en) * | 2001-03-01 | 2004-09-14 | Cordis Corporation | Flexible stent |
US6955686B2 (en) | 2001-03-01 | 2005-10-18 | Cordis Corporation | Flexible stent |
AU784552B2 (en) * | 2001-03-02 | 2006-05-04 | Cardinal Health 529, Llc | Flexible stent |
US7727221B2 (en) | 2001-06-27 | 2010-06-01 | Cardiac Pacemakers Inc. | Method and device for electrochemical formation of therapeutic species in vivo |
US6605110B2 (en) * | 2001-06-29 | 2003-08-12 | Advanced Cardiovascular Systems, Inc. | Stent with enhanced bendability and flexibility |
US6776794B1 (en) * | 2001-11-28 | 2004-08-17 | Advanced Cardiovascular Systems, Inc. | Stent pattern with mirror image |
US7090693B1 (en) | 2001-12-20 | 2006-08-15 | Boston Scientific Santa Rosa Corp. | Endovascular graft joint and method for manufacture |
US7125464B2 (en) * | 2001-12-20 | 2006-10-24 | Boston Scientific Santa Rosa Corp. | Method for manufacturing an endovascular graft section |
US6776604B1 (en) | 2001-12-20 | 2004-08-17 | Trivascular, Inc. | Method and apparatus for shape forming endovascular graft material |
US20040068314A1 (en) * | 2002-01-16 | 2004-04-08 | Jones Donald K. | Detachable self -expanding aneurysm cover device |
US7097850B2 (en) * | 2002-06-18 | 2006-08-29 | Surmodics, Inc. | Bioactive agent release coating and controlled humidity method |
US20030234243A1 (en) * | 2002-06-20 | 2003-12-25 | Mccoy Edward D. | Multi-axis laser apparatus and process for the fine cutting of tubing |
US6865810B2 (en) * | 2002-06-27 | 2005-03-15 | Scimed Life Systems, Inc. | Methods of making medical devices |
US20040024485A1 (en) * | 2002-07-31 | 2004-02-05 | Mccoy Edward D. | Multi-axis laser apparatus and process for the fine cutting of tubing |
US20040054398A1 (en) * | 2002-09-13 | 2004-03-18 | Cully Edward H. | Stent device with multiple helix construction |
WO2004032795A2 (en) * | 2002-10-09 | 2004-04-22 | Fossa Medical, Inc. | Eccentric lumen stents |
US6916409B1 (en) * | 2002-12-31 | 2005-07-12 | Advanced Cardiovascular Systems, Inc. | Apparatus and process for electrolytic removal of material from a medical device |
US7055237B2 (en) * | 2003-09-29 | 2006-06-06 | Medtronic Vascular, Inc. | Method of forming a drug eluting stent |
US20050161549A1 (en) * | 2003-12-30 | 2005-07-28 | Hainline Truman D. | Coil winding machine |
US7153411B2 (en) * | 2003-12-30 | 2006-12-26 | Boston Scientific Scimed, Inc. | Method for cleaning and polishing metallic alloys and articles cleaned or polished thereby |
US7265317B2 (en) * | 2004-01-28 | 2007-09-04 | Boston Scientific Scimed, Inc. | Method of cutting material with hybrid liquid-jet/laser system |
US20060122693A1 (en) * | 2004-05-10 | 2006-06-08 | Youssef Biadillah | Stent valve and method of manufacturing same |
US20060122692A1 (en) * | 2004-05-10 | 2006-06-08 | Ran Gilad | Stent valve and method of using same |
US20060122686A1 (en) * | 2004-05-10 | 2006-06-08 | Ran Gilad | Stent and method of manufacturing same |
US20060025852A1 (en) * | 2004-08-02 | 2006-02-02 | Armstrong Joseph R | Bioabsorbable self-expanding endolumenal devices |
US20060125144A1 (en) * | 2004-12-14 | 2006-06-15 | Jan Weber | Stent and stent manufacturing methods |
US7947207B2 (en) | 2005-04-12 | 2011-05-24 | Abbott Cardiovascular Systems Inc. | Method for retaining a vascular stent on a catheter |
US7763198B2 (en) * | 2005-04-12 | 2010-07-27 | Abbott Cardiovascular Systems Inc. | Method for retaining a vascular stent on a catheter |
US20090062909A1 (en) | 2005-07-15 | 2009-03-05 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
CA2615452C (en) | 2005-07-15 | 2015-03-31 | Micell Technologies, Inc. | Polymer coatings containing drug powder of controlled morphology |
US7833261B2 (en) * | 2005-12-12 | 2010-11-16 | Advanced Cardiovascular Systems, Inc. | Severable support for a stent |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8089029B2 (en) * | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
CA2996768C (en) | 2006-04-26 | 2020-12-08 | Micell Technologies, Inc. | Coatings containing multiple drugs |
JP2009545407A (en) | 2006-08-02 | 2009-12-24 | ボストン サイエンティフィック サイムド,インコーポレイテッド | End prosthesis with 3D decomposition control |
JP2010503489A (en) | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | Biodegradable endoprosthesis and method for producing the same |
WO2008034013A2 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Medical devices and methods of making the same |
WO2008034066A1 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Bioerodible endoprostheses and methods of making the same |
DE602007011114D1 (en) | 2006-09-15 | 2011-01-20 | Boston Scient Scimed Inc | BIODEGRADABLE ENDOPROTHESIS WITH BIOSTABILES INORGANIC LAYERS |
WO2008036548A2 (en) | 2006-09-18 | 2008-03-27 | Boston Scientific Limited | Endoprostheses |
ES2506144T3 (en) | 2006-12-28 | 2014-10-13 | Boston Scientific Limited | Bioerodible endoprosthesis and their manufacturing procedure |
CA2679712C (en) | 2007-01-08 | 2016-11-15 | Micell Technologies, Inc. | Stents having biodegradable layers |
US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
US20080234800A1 (en) * | 2007-03-20 | 2008-09-25 | Medtronic Vascular, Inc. | Stent Including a Toggle Lock |
US8062378B2 (en) * | 2007-03-26 | 2011-11-22 | Mx Orthopedics Corp. | Proximal self-locking long bone prosthesis |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US8226701B2 (en) | 2007-09-26 | 2012-07-24 | Trivascular, Inc. | Stent and delivery system for deployment thereof |
US8663309B2 (en) | 2007-09-26 | 2014-03-04 | Trivascular, Inc. | Asymmetric stent apparatus and method |
US8066755B2 (en) | 2007-09-26 | 2011-11-29 | Trivascular, Inc. | System and method of pivoted stent deployment |
CN101917929A (en) | 2007-10-04 | 2010-12-15 | 特里瓦斯库拉尔公司 | Modular vascular graft for low profile percutaneous delivery |
US8221821B1 (en) | 2007-11-09 | 2012-07-17 | Abbott Cardiovascular Systems Inc. | Methods of modifying ablumenal/lumenal stent coating thicknesses |
US8328861B2 (en) | 2007-11-16 | 2012-12-11 | Trivascular, Inc. | Delivery system and method for bifurcated graft |
US8083789B2 (en) | 2007-11-16 | 2011-12-27 | Trivascular, Inc. | Securement assembly and method for expandable endovascular device |
EP2271294B1 (en) | 2008-04-17 | 2018-03-28 | Micell Technologies, Inc. | Stents having bioabsorbable layers |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
JP2011528275A (en) | 2008-07-17 | 2011-11-17 | ミセル テクノロジーズ,インク. | Drug delivery medical device |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
EP2403546A2 (en) | 2009-03-02 | 2012-01-11 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
CA2756307C (en) * | 2009-03-23 | 2017-08-08 | Micell Technologies, Inc. | Peripheral stents having layers and reinforcement fibers |
CN102481195B (en) | 2009-04-01 | 2015-03-25 | 米歇尔技术公司 | Drug delivery medical device |
WO2010121187A2 (en) | 2009-04-17 | 2010-10-21 | Micell Techologies, Inc. | Stents having controlled elution |
EP2453834A4 (en) | 2009-07-16 | 2014-04-16 | Micell Technologies Inc | Drug delivery medical device |
US8298279B2 (en) * | 2009-09-24 | 2012-10-30 | Medtronic Vascular, Inc. | Stent including a toggle lock strut |
US11369498B2 (en) * | 2010-02-02 | 2022-06-28 | MT Acquisition Holdings LLC | Stent and stent delivery system with improved deliverability |
US8668732B2 (en) | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
WO2011133655A1 (en) | 2010-04-22 | 2011-10-27 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
CA2805631C (en) | 2010-07-16 | 2018-07-31 | Micell Technologies, Inc. | Drug delivery medical device |
CA2841360A1 (en) | 2011-07-15 | 2013-01-24 | Micell Technologies, Inc. | Drug delivery medical device |
US20130035753A1 (en) * | 2011-08-01 | 2013-02-07 | Abbott Cardiovascular Systems Inc. | Multiple Scaffold Design And Coating Thereof |
US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
WO2013114358A1 (en) * | 2012-01-30 | 2013-08-08 | Hipokrat | Negatively charged vascular stent |
US8992595B2 (en) | 2012-04-04 | 2015-03-31 | Trivascular, Inc. | Durable stent graft with tapered struts and stable delivery methods and devices |
US9498363B2 (en) | 2012-04-06 | 2016-11-22 | Trivascular, Inc. | Delivery catheter for endovascular device |
EP2956088A2 (en) | 2013-02-12 | 2015-12-23 | OssDsign AB | Mosaic implants, kits and methods for correcting bone defects |
US9220597B2 (en) * | 2013-02-12 | 2015-12-29 | Ossdsign Ab | Mosaic implants, kits and methods for correcting bone defects |
KR20150143476A (en) | 2013-03-12 | 2015-12-23 | 미셀 테크놀로지즈, 인코포레이티드 | Bioabsorbable biomedical implants |
KR102079613B1 (en) | 2013-05-15 | 2020-02-20 | 미셀 테크놀로지즈, 인코포레이티드 | Bioabsorbable biomedical implants |
US10881519B2 (en) | 2014-08-14 | 2021-01-05 | Ossdsign Ab | Bone implants for correcting bone defects |
JP7002457B2 (en) | 2016-02-08 | 2022-01-20 | ブロックワイズ エンジニアリング エルエルシー | Radial compression device and method of using it to gradually compress articles |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4733665A (en) | 1985-11-07 | 1988-03-29 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4800882A (en) | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US4907336A (en) | 1987-03-13 | 1990-03-13 | Cook Incorporated | Method of making an endovascular stent and delivery system |
US5035706A (en) | 1989-10-17 | 1991-07-30 | Cook Incorporated | Percutaneous stent and method for retrieval thereof |
US5041126A (en) | 1987-03-13 | 1991-08-20 | Cook Incorporated | Endovascular stent and delivery system |
US5102417A (en) | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US5147385A (en) | 1989-11-01 | 1992-09-15 | Schneider (Europe) A.G. | Stent and catheter for the introduction of the stent |
US5496365A (en) * | 1992-07-02 | 1996-03-05 | Sgro; Jean-Claude | Autoexpandable vascular endoprosthesis |
EP0714641A2 (en) * | 1994-11-28 | 1996-06-05 | Advanced Cardiovascular Systems, Inc. | Method and apparatus for direct laser cutting of metal stents |
WO1997004721A1 (en) * | 1995-07-25 | 1997-02-13 | Medstent Inc. | Expandible stent |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5922020A (en) * | 1996-08-02 | 1999-07-13 | Localmed, Inc. | Tubular prosthesis having improved expansion and imaging characteristics |
US5725519A (en) * | 1996-09-30 | 1998-03-10 | Medtronic Instent Israel Ltd. | Stent loading device for a balloon catheter |
US5893867A (en) * | 1996-11-06 | 1999-04-13 | Percusurge, Inc. | Stent positioning apparatus and method |
-
1998
- 1998-05-14 CA CA002308396A patent/CA2308396A1/en not_active Abandoned
- 1998-05-14 WO PCT/CA1998/000471 patent/WO1998051238A1/en active Application Filing
- 1998-05-14 US US09/423,813 patent/US6344055B1/en not_active Expired - Fee Related
- 1998-05-14 AU AU74209/98A patent/AU7420998A/en not_active Abandoned
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5102417A (en) | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4739762A (en) | 1985-11-07 | 1988-04-26 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4733665A (en) | 1985-11-07 | 1988-03-29 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4739762B1 (en) | 1985-11-07 | 1998-10-27 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4733665B1 (en) | 1985-11-07 | 1994-01-11 | Expandable Grafts Partnership | Expandable intraluminal graft,and method and apparatus for implanting an expandable intraluminal graft |
US4907336A (en) | 1987-03-13 | 1990-03-13 | Cook Incorporated | Method of making an endovascular stent and delivery system |
US5041126A (en) | 1987-03-13 | 1991-08-20 | Cook Incorporated | Endovascular stent and delivery system |
US4800882A (en) | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US5035706A (en) | 1989-10-17 | 1991-07-30 | Cook Incorporated | Percutaneous stent and method for retrieval thereof |
US5147385A (en) | 1989-11-01 | 1992-09-15 | Schneider (Europe) A.G. | Stent and catheter for the introduction of the stent |
US5496365A (en) * | 1992-07-02 | 1996-03-05 | Sgro; Jean-Claude | Autoexpandable vascular endoprosthesis |
EP0714641A2 (en) * | 1994-11-28 | 1996-06-05 | Advanced Cardiovascular Systems, Inc. | Method and apparatus for direct laser cutting of metal stents |
WO1997004721A1 (en) * | 1995-07-25 | 1997-02-13 | Medstent Inc. | Expandible stent |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6743252B1 (en) | 1998-12-18 | 2004-06-01 | Cook Incorporated | Cannula stent |
AU743675B2 (en) * | 1998-12-18 | 2002-01-31 | Cook Medical Technologies Llc | Cannula stent |
WO2000035378A1 (en) * | 1998-12-18 | 2000-06-22 | Cook Incorporated | Cannula stent |
WO2001061080A1 (en) * | 2000-02-14 | 2001-08-23 | Advanced Cardiovascular Systems, Inc. | Electro-polishing fixture and electrolyte solution for polishing nitinol stents and method of using same |
US6375826B1 (en) | 2000-02-14 | 2002-04-23 | Advanced Cardiovascular Systems, Inc. | Electro-polishing fixture and electrolyte solution for polishing stents and method |
EP1132058A1 (en) * | 2000-03-06 | 2001-09-12 | Advanced Laser Applications Holding S.A. | Intravascular prothesis |
US8267991B2 (en) | 2000-03-06 | 2012-09-18 | Boston Scientific Scimed, Inc. | Intraluminar perforated radially expandable drug delivery prosthesis and a method for the production thereof |
US7135039B2 (en) | 2000-03-06 | 2006-11-14 | Boston Scientific Scimed, Inc. | Intraluminar perforated radially expandable drug delivery prosthesis and a method for the production thereof |
EP1294309A1 (en) * | 2000-05-22 | 2003-03-26 | Jungsung Medical Co. LTD | Metal stent for insertion in coronary artery |
EP1294309A4 (en) * | 2000-05-22 | 2007-03-07 | Jungsung Medical Co Ltd | Metal stent for insertion in coronary artery |
EP1557140A2 (en) * | 2001-02-05 | 2005-07-27 | Conor Medsystems, Inc. | Expandable medical device |
EP1557140A3 (en) * | 2001-02-05 | 2005-08-10 | Conor Medsystems, Inc. | Expandable medical device |
EP1676547A1 (en) * | 2001-02-05 | 2006-07-05 | Conor Medsystems, Inc. | Expandable medical device |
EP1266637A1 (en) * | 2001-06-11 | 2002-12-18 | Cordis Neurovascular, Inc. | Method of manufacturing small profile medical devices |
US6612012B2 (en) | 2001-06-11 | 2003-09-02 | Cordis Neurovascular, Inc. | Method of manufacturing small profile medical devices |
EP1413261A1 (en) * | 2002-10-23 | 2004-04-28 | Medtronic Vascular, Inc. | Stent with detachable ends |
US7389670B1 (en) | 2004-07-26 | 2008-06-24 | Abbott Laboratories | Stent crimping system |
US7628051B1 (en) | 2004-07-26 | 2009-12-08 | Abbott Laboratories | Stent crimping system |
US8215149B1 (en) | 2004-07-26 | 2012-07-10 | Abbott Laboratories | Stent crimping system and method |
US7722661B2 (en) | 2007-12-19 | 2010-05-25 | Boston Scientific Scimed, Inc. | Stent |
US7922756B2 (en) | 2007-12-19 | 2011-04-12 | Boston Scientific Scimed, Inc. | Stent |
Also Published As
Publication number | Publication date |
---|---|
AU7420998A (en) | 1998-12-08 |
US6344055B1 (en) | 2002-02-05 |
CA2308396A1 (en) | 1998-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6344055B1 (en) | Method for production of an expandable stent | |
EP1968503B1 (en) | Stent | |
US6746477B2 (en) | Expandable stent | |
EP1887993B1 (en) | Stent side branch deployment initiation geometry | |
EP2068762B1 (en) | Intra-columnar cell features to improve drug distribution and scaffolding of a stent | |
US20050182477A1 (en) | Intraluminal stent and graft | |
AU1472800A (en) | Stent having non-uniform structure | |
JP2003503102A (en) | Variable thickness stent and method of manufacturing the same | |
WO2012035550A2 (en) | Stents with low strut thickness and variable strut geometry | |
US9814610B2 (en) | Stent with elongating struts | |
JP2010246987A (en) | Small vessel expandable stent and method for production of same | |
AU8201898A (en) | Expandable stent | |
AU782963B2 (en) | Expandable stent | |
EP1407725A2 (en) | Expandable stent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref document number: 1998548640 Country of ref document: JP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
ENP | Entry into the national phase |
Ref document number: 2308396 Country of ref document: CA Kind code of ref document: A Ref document number: 2308396 Country of ref document: CA |
|
122 | Ep: pct application non-entry in european phase | ||
WWE | Wipo information: entry into national phase |
Ref document number: 09423813 Country of ref document: US |